D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
PLRX holding history
Pliant Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PLRX overviewAll 13F holders of PLRXFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −10,679−100.0% | Sold out | Holders |
| Q2 2024 | 10,679 | $114.8K | <0.1% | +10,679 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −48,999−100.0% | Sold out | Holders |
| Q3 2023 | 48,999 | $849.6K | <0.1% | −369,664−88.3% | Reduced | Holders |
| Q2 2023 | 418,663 | $7.59M | <0.1% | −61,846−12.9% | Reduced | Holders |
| Q1 2023 | 480,509 | $12.8M | <0.1% | +266,708+124.7% | Added | Holders |
| Q4 2022 | 213,801 | $4.13M | <0.1% | −1,514−0.7% | Reduced | Holders |
| Q3 2022 | 215,315 | $4.50M | <0.1% | +143,260+198.8% | Added | Holders |
| Q2 2022 | 72,055 | $577.0K | <0.1% | −18,054−20.0% | Reduced | Holders |
| Q1 2022 | 90,109 | $632.0K | <0.1% | +40,554+81.8% | Added | Holders |
| Q4 2021 | 49,555 | $669.0K | <0.1% | −26,439−34.8% | Reduced | Holders |
| Q3 2021 | 75,994 | $1.28M | <0.1% | −13,727−15.3% | Reduced | Holders |
| Q2 2021 | 89,721 | $2.61M | <0.1% | +13,374+17.5% | Added | Holders |
| Q1 2021 | 76,347 | $3.00M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.